Vaccine tested to stop parasite reinfection in kids
NCT ID NCT00870649
Summary
This study tested whether a new vaccine, called Bilhvax, could help prevent children from getting sick again with urinary schistosomiasis, a parasitic infection. The trial involved 250 infected children aged 6-9 in Senegal. All children received the standard drug treatment (praziquantel), and then half received the vaccine while the other half received a placebo, to see if the vaccine delayed the return of the infection over three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHISTOSOMA HAEMATOBIUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ESPOIR Pour La Santé
Saint-Louis, Senegal
Conditions
Explore the condition pages connected to this study.